Atria Investments LLC Magenta Therapeutics, Inc. Transaction History

Atria Investments LLC

  • $7.56 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$6.03 - $15.24 $74,506 - $188,305
-12,356 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$9.07 - $15.84 $112,068 - $195,719
12,356 New
12,356 $187,000
Q2 2019

Aug 09, 2019
SELL
$13.4 - $17.67 $158,053 - $208,417
-11,795 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$5.7 - $19.7 $67,231 - $232,361
11,795 New
11,795 $194,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Atria Investments LLC Portfolio

Follow Atria Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email